Vicapsys Life Sciences, Inc.

Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary

Vicapsys Life Sciences (OTC Pink: VICP) adopted a new corporate identity developed by FutureBrand for itself and its Stateline Distributors subsidiary, the first step in post-merger corporate housekeeping following the September 3, 2026 reverse merger. The company is mid-process on its Rule 15c2-11/Form 211 quotation effort, an OTCID Basic Market application, and a PCAOB audit intended to produce audited financials for the combined business. It is also preparing to secure financing to fund capital expenditures and acquisition benchmarks, including closing the NitroMist acquisition upon FDA acknowledgment of the NDA transfer and a Puerto Rico facility acquisition — none of which is yet completed or priced.

•1mo ago

Vicapsys Life Sciences Announces Advisory Board Following Completion of Stateline Merger

Vicapsys Life Sciences (OTC: VICP) announced its Advisory Board following the September 3, 2026 completion of its reverse merger with Stateline Distributors of Puerto Rico. The eight advisors span federal and tribal health contracting, pharmaceutical manufacturing and quality, oncology distribution, brand strategy, and institutional purchasing — areas matching the company's stated strategy. Key execution items remain outstanding: the NitroMist acquisition and relaunch, a planned Puerto Rico manufacturing facility acquisition and requalification, and completion of the PCAOB audit. No financial figures were disclosed.

•1mo ago